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Human embryonic stem cells (hESCs) are conventionally expanded and maintained in vitro on biological substrates. Synthetic electrospun polymer nanofibers have potential to act as non-biological substrates in the culture of hESCs. Three synthetic, FDA approved polymers: poly-ɛ-caprolactone (PCL), poly-L-lactic acid (PLLA) and poly lactic-co-glycolic acid (PLGA) were electrospun as nanofibers (random or aligned conformations) on glass coverslips and their supportive role in hESC culture examined. Clonogenicity experiments demonstrated that nanofibrous scaffolds (PCL aligned and random, PLLA aligned and PLGA aligned) supported hESC adhesion and expansion. A significantly greater number of colonies were observed on PCL-aligned nanofibrous scaffolds in comparison to PLLA-aligned and PLGA-aligned substrates (p < 0.05). hESC colonies were significantly larger on PCL aligned nanofibrous substrates when compared to other polymer substrates (p < 0.05 – 0.001), where fiber diameter played a pivotal role in support of hESC clonogenicity (on PCL). Retention of pluripotentiality was confirmed by expression of Alkaline phosphatase, OCT-3/4 and Nanog expression on PCL scaffolds and the expression of transcripts representative of mesoderm (ACTC1), ectoderm (SOX1) and endoderm (AFP) during subsequent spontaneous in vitro differentiation. These results demonstrate the potential of nanofibers as xeno-free scaffolds supportive of hESC adhesion, self-renewal and differentiation in, in vitro culture condition.
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The applications of stem cells in tissue engineering and regenerative medicine technologies have grown rapidly over the past decade. Autologous, adult and cord-derived, stem cells have been implanted into patients for treatment of numerous indications including haematological, musculoskeletal, and immunological disorders [1]. Recent approvals for hESC-based clinical trials for the treatment of macular degeneration and spinal cord injury have expanded this list and is anticipated to grow over the coming years, for instance with the proposed use of induced pluripotent stem cells (iPS) in the treatment of macular degeneration [2,3]. Particular attention has been drawn towards hESC due to their pluripotentiality, immortality, and immunologically privileged nature [4]. These characteristics endow great potential as an off-the-shelf, allogeneic, scalable solution to numerous conditions, for which, adult and cord-derived stem cells are not applicable, due to limited differentiation and/or proliferative capacities [5]. 

Current methodology for expansion of hESCs is largely reliant on either mitotically-inactivated feeder cell methods, or the feeder-free method, which utilizes feeder cell, pre-conditioned, or defined, media and a biological substrate, such as Matrigel™  ADDIN EN.CITE [4, 6-9]. Matrigel™ itself is a loosely defined substrate, which consists of extracellular matrix proteins ECM) from Engelbreth-Holm-Swarm tumours [6]. The inherent limitation of Matrigel™ is its unsuitability for incorporation into hESC-based clinical trials due to the risk of xenocontamination through the expressed concern of foreign oligosachharide residues such as Sialic acid identified on the surfaces of hESCs, which could subsequently elicit an immune response during implantation [10]. Additionally, Matrigel™ limits hESC expansion to a two dimensional (2D) environment with subsequent interventions required prior to transplantation. Alternative substrates, which have attempted to eliminate Matrigel™-associated limitations, have included coating flasks with ECM proteins such as fibronectin, laminin and collagen  ADDIN EN.CITE [7-14]. However, these proteins are expensive to produce and purify, display batch-to-batch variability, limit expansion to a 2D environment, and have degradation and denaturation potential once dehydrated. Hence, innovative and novel tissue engineering strategies are required to provide three dimensional (3D) carriers to facilitate transplantation to in vivo target sites.

Cells are sensitive to nano-scale topography [15]. A common method used for fabricating nano-scale scaffolds is electrospinning [16]. Electrospun nanofiber scaffolds have displayed good biocompatibility in the support of attachment, proliferation and differentiation of human bone marrow-derived mesenchymal stem cells (hMSC), cord blood-derived somatic stem cells, neural stem cells, and haematopoietic stem cells  ADDIN EN.CITE [15, 17-26]. The utilization of nanofibrous substrates to support stem cell culture has been explored in ESCs derived from distinct species including rhesus monkey, murine (extensively) but is limited with human  ADDIN EN.CITE [27-36]. The majority of these studies have focused on the use of nanofibrous substrates in the support of ESC differentiation towards neural lineages and little work appears to be performed outside this towards other lineages. In one instance, hESC were pre-differentiated into neural progenitors (NPs) in adherent cultures before seeding onto electrospun nanofibrous scaffolds fabricated from UltraWeb™ [28] and Polyamide [30]. These supported successful differentiation towards both neurons and glial cells when combined with neurogenic differentiation media. Similarly, hESC-derived NPs were seeded onto Tussah silk fibroin nanofibrous scaffolds of varying fiber diameter (400 nm and 800 nm) in both aligned and random conformations. These scaffolds also demonstrated a supportive capacity for cell survival, migration, and differentiation of NPs. In particular, aligned, 400 nm diameter fiber substrates significantly elevated neuronal differentiation and neural outgrowth [31]. Alternatively, mouse embryonic stem cells (mESCs)-derived embryoid bodies (EBs) were seeded onto PCL electrospun nanofibrous substrates (aligned and random) with and without retinoic acid differentiation media and differentiated towards neural progenitors [32]. Finally, hESCs were seeded directly onto electrospun polyurethane scaffolds, expanded for 5 days before being switched to a program of neuronal differentiation. While neuronal differentiation was successful there is no evidence of hESC maintenance of a pluripotent phenotype on the polyurethane scaffolds [33]. 

There are a limited number of studies describing the successful expansion of undifferentiated human ESCs on electrospun nanofibrous scaffolds, which have been subsequently modified, and thus appears to be a relatively unexplored area but of high importance  ADDIN EN.CITE [29, 34]. Microfibrous (3 µm fiber diameter) scaffolds were fabricated from poly (desaminotyrosyl tyrosine ethyl ester carbonate) (pDTEc), surface treated with natural and synthetic materials including: laminin, fibronectin, collagen I, vitronectin, Matrigel™, poly D lysine (PDL), and poly-L-ornithine (PLO); and then further conditioned with mTeSR. pDTEc scaffolds coated with either natural proteins, Matrigel™, or PDL supported hESC self-renewal. However, naked pDTEc nanofibrous substrates did not support the self-renewal of hESCs [29]. Finally, co-culture of hESCs and MEFs on electrospun nanofibrous substrates of hybrid polymers including PCL/collagen and PCL/gelatin revealed successful expansion of undifferentiated hESCs with retention of pluripotent characteristics shown by the expression of OCT-4, TRA-1-60, GCTM-2, NANOG and SOX-2 [34]. However, when all of the above previous descriptions are taken together it remains clear that there are, prior to this report, no descriptions of the successful culture and expansion of undifferentiated hESCs on purely synthetic electrospun polymer-based nanofibers without the combinatory use of feeder cells or natural biological molecules.
 




Fabrication of nanofiber scaffolds via electrospinning
PCL (Mw 80 000; Sigma, UK), PLGA (96L/4D; L:G 80/20, Purac BV, Netherlands) and PLLA (Purac, BV, Netherlands) were electrospun in two different conformations (aligned or random) and coated onto glass coverslips (24 x 24 mm), which were mounted onto the relevant collector type prior to electrospinning. Electrospinning solutions were prepared using the solvents listed in Table 1. Random nanofiber scaffolds were fabricated by deposition onto a static, negatively charged collector. Aligned nanofiber scaffolds were collected using a rotating mandrel (ca. 5,250 rpm), as described previously by our group [25]. Nanofiber scaffold orientation was indicated via suffixing R for random and A for aligned after the polymer name. Electrospinning parameters used to attain each type of scaffold are stated in Table 1. PCL was also electrospun at two different concentrations (12.5 % and 15 %) in both aligned and random conformations in order to attain PCL nanofibrous substrates with various fiber diameters. Nanofiber scaffold attachment on glass coverslips was reinforced with silicone rubber strips (Silex Ltd, Borden, UK), which were adhered using silicone glue (RS Scientific, Corby, UK). All scaffolds and blank coverslips for controls (positive control, Matrigel™ coated glass coverslip; negative control, naked glass coverslip) were sterilised by immersion in methylated ethanol (70 %) for a minimum of one hour prior to coating and seeding.
Human embryonic stem cell culture
hESCs (SHEF1; UK Stem Cell Bank) were cultured on Matrigel™ (BD Biosciences, Oxford, UK) with conditioned culture media prepared using mouse embryonic fibroblasts (MEFs) as described previously [12]. In brief, hESC media was composed of Knock-out (KO) DMEM (Gibco-Invitrogen, Paisley, UK) supplemented with 20 % KO Serum Replacement (Gibco-Invitrogen, UK), 1 % L-glutamine (Lonza, Slough, UK), 1 % non-essential amino acids (NEAA; Lonza, Slough, UK), 4 ng/ml basic fibroblastic growth factor (Lonza, Slough, UK) and 0.1 mM βmercaptoethanol (Gibco-Invitrogen, UK). hESC media was conditioned overnight on sub-confluent MEFs and then further supplemented with basic fibroblastic growth factors (bFGF; 4 ng/ml) and sterile filtered (Millipore, Watford, UK) before use.







Seeding of hESCs onto nanofiber scaffolds
Nanofibrous scaffolds and controls (positive control, Matrigel™-coated coverslip; negative control, naked glass) were seeded with hESCs (SHEF1, Passage 42), in 2 % O2 conditions. Cell seeding density was 1700 cells/cm2 per sample. hESC were initially seeded in MEF-conditioned media (500 µl) and all samples were incubated in 2 % O2 overnight, after which, each petri dish was flooded with 6 ml of MEF-conditioned hESC media and colonies recovered over a 21 day period without change of media to determine the clonogenic capacity of the population (4). For each sample type (controls and scaffolds), n=3 where each n contained repeats in triplicate.

Colony quantification





Light microscopy was performed using a bright field Nikon Eclipse TS-100 light microscope equipped with a Canon EOS 400D digital SLR camera.

Characterisation of pluripotency of hESCs
hESC colonies on Matrigel™ (positive control) and PCL nanofibrous substrates (aligned and random) were cultured in 2 % O2 for 21 days before immunoassaying for pluripotent marker expression. Media was removed and hESC colonies fixed in paraformaldehyde (4 % in PBS) for 40 min, washed with PBS, treated with Triton-X (0.5 %) for 5 min and non-specific proteins blocked with 3 % bovine serum albumin for 1 hour at room temperature. hESC colonies were then incubated with 1 µg/100 µl working solution of primary anti-human monoclonal antibodies; mouse anti-alkaline phosphatase (Clone B4-78 – Isotype mouse IgG, Part # 96), goat anti-Nanog (Part # 963488) and goat anti-Oct-3/4 (Part # 962649) overnight at 2 – 8 ᵒ C (SC008; R & D Biosystems). hESCs were next washed three times with PBS before being incubated with 5 µg/ml for two hours at room temperature with either; donkey anti-mouse IgG (NL557; R & D Biosystems) to detect alkaline phosphatase, donkey anti-goat IgG (NL003; R & D Biosystems) to detect Nanog and Oct-3/4. Nuclei were visualised by counter staining with DAPI and mounted with Vectashield (Vector Laboratories, Burlingame, CA). Images were recorded on a fluorescent microscope (Nikon TZ1; Leica, Germany). 

Spontaneous differentiation of hESCs 
After 21 days of culture hESC colonies on PCL nanofiber scaffolds were transferred into spontaneous differentiation media consisting of KO DMEM, foetal bovine serum (10 %), L-glutamine (1 %), NEAA (1 %) and βmercaptoethanol (0.1 mM) with media changed every 3 days. Cell lysis was performed in situ at specific time points ranging from day 0 to day 20 for RNA extraction. Cell lysates were prepared and homogenised following manufacturer’s protocols (RNeasy, Qiagen, Crawley, UK) and stored at -80 °C ready for subsequent RNA extraction. 
 
Semi-quantitative reverse transcriptase-polymer chain reaction analysis 
RNA was extracted using the RNeasy Mini Kit according to manufacturer’s instructions (Qiagen, Crawley, UK) and quantified on a Nanodrop spectrophotometer (ND1000; Thermo Scientific, Dorset, UK). Semi-quantitative RT-PCR (reverse transcriptase polymerase chain reaction) analysis was performed on RNA samples for hESCs cultured on all scaffold types (Matrigel™ coated coverslips, PCL aligned and random nanofibers) at 0, 5, 10 and 20 days. One-step RT-PCR was performed using the SuperScript® III One-Step RT-PCR System with Platinum® Taq DNA Polymerase (Invitrogen, Paisley, UK) according to manufacturers’ instructions. Primers (F indicates Forward Primer, R indicates Reverse Primer, annealing temperature used is indicated for each primer pair) were designed for GAPDH, POU5F1, hTERT, SOX1, ACTC 1 and AFP using Primer3 freeware [35 36], see Table 2. All RT-PCR reactions comprised a single cycle of 50 °C for 30 min, a single cycle of 94 °C for 2 min, followed by 30 cycles of: 94 °C for 15 sec, primer specific annealing temperature (see above) for 30 sec, and 68 °C for 1 min, this was followed by a final extension of 68 °C for 5 min. Gel electrophoresis confirmed PCR product amplification.

Electron microscopy
Field Emission Scanning Electron Microscopy (FESEM) samples were coated with gold using an Emscope 200 (Emscope, UK) sputter coater for two mins prior to analysis. Samples were analysed using a Hitachi F4500, (Hitachi, UK) FESEM. FESEM images of nanofibers were analysed using Image J. Image J was calibrated according to the image magnification and the diameters of 50 individual fibers were selected randomly and measured. Once the data for the measurements was collected for each polymer/orientation, the average nanofiber diameter and standard deviations were calculated. 

Statistical analysis 
Error bars on graphs indicate standard deviations (SD). Data were tested for normality and a one-way ANOVA/Kruskall Wallis test was performed followed by an appropriate post-test (Tukey’s or Dunns, respectively) to determine the origins of significance. In this study significance levels are indicated according to the legend p<0.05a, p<0.01b and p<0.001c.







Random and aligned nanofibers of three different synthetic, FDA approved, polymers were electrospun following previous demonstrations of their use in the successful recovery, isolation and expansion of bone marrow-derived hMSCs [25]. The morphology and diameter of both random and aligned fibers characterised by FESEM are presented in Figure 1A. PCL nanofibers (aligned 280 nm; random 318 nm) had a smaller diameter in comparison to PLGA (aligned 769 nm; random 1229 nm) and PLLA (aligned 2506 nm; random 1028 nm) nanofibers, in both aligned and random conformations. Significant differences in the fiber diameters between aligned and random conformations were apparent within each polymer type when electrospun with identical solution concentrations (Figure 1B). PLLA-A fibers displayed significantly greater fiber diameters in comparison to PLLA-R fibers whereas; PLGA-R fibers had a significantly greater diameter than aligned counterparts.

hESC clonogenicity on nanofibrous surfaces
Clonogenicity gives an indication of the overall self renewal capacity of the stem cell population where individual cells which give rise to colonies of greater than 50 cells are termed as colony forming units (CFU) [4]. As expected Matrigel™ coated coverslips (positive control) yielded significantly more hESC CFUs than the nanofiber-coated surfaces in 2 % O2 with 5.9 CFUs per coverslip (pc) in comparison to ≤ 2 CFUs on nanofibrous substrates (Figure 2) (p < 0.05-0.001). Of the nanofibrous substrates tested, PCL proved to be the most efficient polymer for the adherence and expansion of hESC CFUs in 2 % O2. In particular, PCL-A (2.2 CFUs/pc) significantly supported a greater number of hESC CFU’s in comparison to other polymer nanofibrous substrates including; PLGA (aligned, 0.5 CFUs/pc; random, 0 CFUs/pc) and PLLA (aligned, 0.2 CFUs/pc; random, 0 CFUs/pc) (p < 0.05-0.001). PCL-A provided a 2-fold increase over its PCL-R counterpart, although this was statistically insignificant. The overall schema of colony formation and expansion in 2 % O2 is as follows: Matrigel™ > PCL-A > PCL-R > PLGA-A > PLLA-A > PLGA-R = PLLA-R (Figure 2). 

The size of hESC colonies was determined by manual measurement of colony diameter. Evaluation of colony size revealed that Matrigel™ coated coverslips supported significantly larger CFUs (5 mm Ø; p < 0.05-0.001) in comparison to all nanofibrous substrates. However, amongst the nanofibrous substrates, hESC CFUs formed on PCL-A (2.5 mm Ø) were significantly larger than hESC CFUs formed on PCL-R (0.6 mm Ø), PLGA-A (0.25 mm Ø), PLLA-A (0.1 mm Ø) and PLGA-R and PLLA-R (0 mm Ø) (Figure 3) (p < 0.001). The morphology of hESCs within formed CFU’s expanded on nanofibrous substrates in 2 % O2 was typical of hESC cultured on Matrigel™-coated petri dishes with conditioned media and broadly similar to those cultured on Matrigel™-coated glass coverslips surfaces (Figure 4A). However, hESC CFUs recovered on random nanofibers appeared to be more dense and compact when compared to their aligned counterparts (Figure 4A). Similarities were observed in hESC colony morphology recovered on Matrigel™ and PCL-Aligned nanofibrous substrates (Figure 4B).

hESC retain expression of pluripotency genes after prolonged culture on electrospun PCL nanofibrous substrates.




hESC retain a pluripotent differentiation capacity on electrospun PCL nanofibrous substrates. 
Following recovery, hESC on both PCL-A and -R were transferred, without passage, into spontaneous differentiation media. PCL nanofibers were selected for examination due to the reproducibly significant increased hESC yield versus other polymer types tested.  After 20 days, with regular media changes, a gradual downregulation of POU5F1 and hTERT transcripts was apparent on both Matrigel™-coated coverslips and PCL-A nanofibrous substrates whereas on PCL-R a delay in down regulation was observed (Figure 5B). The retention of a pluripotential differentiation capacity was evidenced by the expression of transcripts associated with; ectoderm (SOX1), endoderm (AFP), and mesoderm (ACTC1). SOX1 and ACTC1 were expressed at similar levels on all scaffold types across the experimental time course. AFP expression was generally lost by day 20 during spontaneous differentiation across all three substrates.

Fiber diameter of PCL nanofibrous substrates dictates hESC Clonogenicity.
We next investigated the role of PCL (optimal polymer for recovering the greatest number of CFU’s) nanofibrous substrate fiber diameter in the adhesion and expansion of hESC. The rationale behind performing this study was due to the differences in fiber diameter witnessed between the three polymers tested previously and hence wanted to investigate, whether PCL electropsun nanofibers with different fiber diameters influenced hESC CFU recovery and expansion. PCL was electrospun with two polymer concentration solutions; 12.5 % (as above) and 15 %, in both aligned and random conformations. Nanofibers electrospun from these solutions were characterised with reference to fiber morphology, substrate topography and fiber diameter (Figure 6). Fiber diameter analysis demonstrated that a 15 % PCL solution generated nanofibers with a significantly larger diameter in both aligned (521 nm) and random (660 nm) conformations, relative to nanofibers fabricated from 12.5 % PCL (aligned, 280 nm; random 318 nm) (Figure 6B) (p < 0.01). The 15 % PCL nanofibers were denoted as “large” and 12.5 % PCL nanofibers were denoted as “small”, in both aligned and random conformations.





Nanofibers are potentially implantable, are biodegradable, eliminate a potential source of xeno-contamination, which accompanies most current and conventional culture of hESCs, and provide exciting opportunities for use in clinical therapeutics. Where nanofiber support of hESC culture in vitro has been previously described, it is reliant on the generation of hybrid polymers or co-culture with a supporting cell layer  ADDIN EN.CITE [33, 34]. This study demonstrates that in a 2 % O2 environment hESCs are, surprisingly, able to adhere to, and self-renew on, electrospun nanofibrous substrates fabricated from synthetic, FDA approved polymers, without the need for additional biological substance treatment. This study opens the door to future research designed to improve and/or tailor purely synthetic PCL nanofibers for the support of hESC culture and differentiation. 

Oxygen Effects on Embryonic Stem Cell Interaction with Nanofibers 
hESC attachment and colony formation on electrospun nanofibrous scaffolds was dependant on various conditions, including the use of a reduced, physiological, oxygen culture environment (2 % O2), polymer material and fiber diameter. Though the precise mechanisms behind this phenomenon are under current exploration it is important to register that global transcriptome analysis of hESC revealed significant upregulation and downregulation of specific integrin sub-units when cultured in 2 % O2, relative to hyperoxic (21 % O2) conditions [37]. For instance, we and others have demonstrated that integrin sub-units; alpha 6, beta 1, beta 4, alpha E, alpha V, and beta 5 are all expressed at significantly higher levels in physiological normoxia (2% O2) relative to hyperoxia (21 % O2)  ADDIN EN.CITE [8, 38, 39]. We previously reported significantly higher αVβ5 integrin receptor expression at transcriptional and translational levels in hESCs cultured in 2% O2 relative to 21% O2. Blockage of αVβ5 in hESCs significantly hindered attachment and compromised nuclear localisation of pluripotency associated markers (Nanog and Oct 3/4) in 2% O2 but not in 21% O2 [40]. These findings therefore suggest that the expression of critical integrin sub-units above a specific threshold (which changes as a result of oxygen environment) can dictate the ability of hESC adhesion and self-renewal  ADDIN EN.CITE [8, 38, 39]. 

We have revealed a synergistic effect on hESC culture when physiological normoxia and nanofiber scaffolds are combined; which may mimic aspects of the in vivo hESC environment. All reports using nanofiber scaffolds in conjunction with either hESC or mESC to date were performed under hyperoxic (21% O2) conditions with either MEF co-culture or the incorporation of ECM molecules into the nanofiber scaffolds  ADDIN EN.CITE [29, 34]. A recent study by Meade et al., 2013 demonstrated the successful differentiation of mESCs towards neural lineages using electrospun PLGA nanofibers (coated with heparin sulphate via plasma treatment) where oxygen levels within the scaffold were recorded as  ~5 % O2 in a 21% O2 incubator condition [41]. From previous reports it is clear that naked nanofiber scaffolds alone either did not support or have not been explored in the support of pluripotent hESC. We hypothesise that under a normoxic (2% O2) oxygen environment, hESCs alter their integrin receptor expression pattern, enabling adhesion to adsorbed proteins on nanofibrous substrates and subsequent colony formation [40]. This hypothesis arises from recent reports detailing changed integrin expression in both hMSCs and hESCs in reduced oxygen culture conditions [42]. These factors may play the central role in enhancing stem cell adhesion and self-renewal. A putative mechanism for this may be the selective adsorption of key ECM proteins on nanofibers altering hESC cytoskeletal morphology on the fibers and the activation of the Rac-AKT-JNK signaling pathway which is linked to the maintenance of stem cell pluripotency [39].

Nanotopographical effects
In addition to the observation that nanofibers could support self-renewal of hESCs we also noted that within each specific polymer sub-type a greater number of hESC colonies were recovered on aligned, as opposed to random, nanofibers. Overall PCL-A nanofibers supported the highest number of CFU’s (Figure 2), and this lies in agreement with the data demonstrated by our group previously where orientation of electrospun nanofibers improved the isolation efficiency of hMSC colonies, derived directly from bone marrow aspirate [25]. Moreover, CFU’s on PCL-A were significantly larger than the other two polymer types (Figure 3). Topography is generally considered to have strong effects on cell activity, as it provides physical guidance, which is able to mimic native fibrillar ECM proteins, a key component of the stem cell niche [43]. Aligned nanofibrous substrates were optimal for both hESC/hMSC adhesion and expansion [25]. An increase in anisotropy is known to increase number of focal adhesion contacts from the cells to the surrounding fibers which may be the reason why aligned nanofibers support larger and greater number of CFU’s [44]. Here, we demonstrate that anisotropy plays an important role in stimulating undifferentiated hESC expansion and colony formation during culture in physiological normoxia.

Fiber Diameter Effect on hESC Clonogenicity
Fiber diameters of <500 nm generally promote cell adhesion and encourage greater cell attachment due to an increased surface area to volume ratio and an associated increase in the probability of focal adhesion sites available for cell attachment [45]. Previous reports describing electrospun nanofibrous substrates for the support of stem cell (hMSCs, human hematopoietic stem cells and human unrestricted somatic stem cells) expansion and differentiation have utilized nanofibers ranging in size from 200 nm to sub- micron fibers (2-3 µm) in both random and aligned conformations  ADDIN EN.CITE [25, 46-48]. Although these have all demonstrated success in supporting various activities (undifferentiated expansion and differentiation towards neural and skeletal lineages) for these stem cells, many of these studies included the use of hMSCs [25, 46, 47], unrestricted somatic stem cells [48] and hematopoietic stem cells [45] on purely synthetic (naked) nanofibrous substrates and were performed under hyperoxic conditions. Interestingly, decreasing fiber diameter has also demonstrated to have an impact on cell activity. For instance a decrease in fiber diameter (random, 3.5 µm – 700 nm; aligned, 1.5 µm – 300 nm) enhanced NSC differentiation (measured by neurite outgrowth) with little effect on cell orientation [17]. Migration of MSCs was also enhanced by decreasing the fiber diameter (from 500- 1000 nm to 50-200 nm) of collagen I nanofibers although cell viability was greater on larger (500-1000 nm) diameter fibers [20]. 

A previous study detailed that nanofiber substrates with 96.3 – 275 nm fiber diameters enhanced colony recovery of hMSCs from bone marrow in comparison to micron fibers (1-2 µm) [25]. Here a direct correlation between CFU size and nanofiber diameter was apparent (Figure 6C). In general agreement we have noted that smaller diameter nanofibrous substrates (aligned and random) supported a significantly greater number of hESC colonies, relative to their larger diameter counterparts, (Figure 6C). This is in agreement with previous reports, which have utilized electrospun nanofibrous substrates with a similar fiber diameter range (250 nm – 360 nm) for ESC culture. However, in these cases either mESC-derived EBs were utilized [32], or hESCs were immediately directed towards NP differentiation and showed the lack of ability to maintain their undifferentiated state [33], or incorporated the use of hybrid polymers (PCL/collagen and PCL/gelatin) and the co-culture of feeder cells in order to expand undifferentiated hESCs [34]. However, it would be useful to characterize fiber stiffness as a result of changing fiber diameter to decipher whether hESC culture is influenced due to geometric, mechanical, or both effects.

Polymer Chemistry and Protein Adsorption 
PCL supported recovery of the greatest number of hESC colonies of the three polymers tested. Colony size, morphology and differentiation capacity of hESCs supported on electrospun PCL nanofibers was very similar to those supported on the positive controls (MatrigelTM). Previous cell-based studies have shown that electrospun PCL nanofibrous scaffolds can successfully support numerous cell types including, schwann cells [21], bone marrow derived-MSCs [46], human cord-blood derived somatic stem cells [23], mouse ESCs [32] and hESCs [34]. PCL was the most hydrophobic polymer we tested, compared to PLGA and PLLA, and supported the largest and greatest number of colonies when compared to the other two polymers investigated. Increased surface area, surface roughness of nanofibers [49], polymer hydrophobicity chemistry all play a crucial role in the adsorption of extracellular matrix proteins to the substrate which can subsequently influence cell attachment, proliferation and stemness [50]. Hence, all these factors can determine the conformation, orientation and quantity [51] of proteins adsorbed to these substrate which allow cell recognition and attachment via corresponding cell integrin receptors [52]. We propose that PCL nanofibrous substrates supported adsorption of appropriate proteins at relevant concentrations and desired conformational/orientation states sufficient to support hESC attachment and expansion.

Conclusion
Successful hESC expansion and differentiation on nanofiber scaffolds realises their potential application as a non-biological xeno-free substrate with concurrent elimination of concerns surrounding the transmission of unintentional agents. hESC expansion and subsequent differentiation was achieved under physiological normoxia (2% O2) when cultured on naked nanofiber scaffolds. The composition, fiber diameter and orientation of the nanofiber all play roles in the quality and quantity of colonies. Nanofiber-scaffolds are cost-effective in comparison to conventional methodology and allow themselves readily to high throughput production processes. This encourages further research on hESC culture on synthetic substrates. Though difficult, this will provide novel opportunities for cell therapy and regenerative medicine applications as implantable devices that are biocompatible and biodegradable in vivo.
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Figure Captions 
Figure 1: Characterization of electrospun nanofibrous substrates. (A) FESEM imaging of PCL, PLGA and PLLA nanofibers. Nanofiber diameters are presented under each image. Arrows indicate the predominant direction of alignment. Scale bar = 3 µm. (B) Average diameters for PCL, PLGA and PLLA. The y-axis indicates Fiber Diameter (nm) while error bars indicate positive standard deviations of n=50; a p < 0.05, b p < 0.01, c p < 0.001. 

Figure 2: Nanofibrous substrate support of hESC clonogenicity is permissive in physiological normoxia. Quantification of colony forming units on nanofibrous substrates under physiological normoxia (2% O2). MatrigelTM is included as the positive control. Values indicate mean number of forming units and positive standard deviation of n=9; a p < 0.05, b p < 0.01, c p < 0.001. The y-axis indicates the number colony –forming units formed on the different types of nanofibrous substrates (aligned and random), which are stated on the x-axis.

Figure 3: hESC colony size is dependent on polymer type and fiber orientation. Quantification of colony size of hESC colonies formed on nanofibrous surfaces in physiological normoxia. MatrigelTM is included as the positive control. Values indicate mean colony size and positive standard deviation of n=9; a p < 0.05, b p < 0.01, c p < 0.001. The y-axis indicates the size of hESC colonies (mm) formed on different types of nanofibrous substrates (aligned and random), which are stated on the x-axis.


Figure 4: Nanofibrous substrate recovered hESCs display typical morphologies (A) hESC morphology on: MatrigelTM is included as the positive control (left), PCL random nanofibers (centre) and PCL aligned nanofibers (right). Scale bar = 200 µm. (B) Colony formation on: (left) MatrigelTM, (right) PCL aligned nanofibrous substrates under physiological normoxia (scale bar = 12 mm). 

Figure 5: Pluripotent marker expression and differentiation of hESCs cultured on nanofibrous substrates. (A) Immunoflourescent staining of pluripotent marker expression in hESCs cultured on nanofibrous substrates (PCL-A and PCL-R) in physiological normoxia for 21 days. Positive expression of ALP, Nanog and Oct-3/4 in MatrigelTM, PCL-aligned nanofibrous substrate, and PCL-random nanofibrous substrate cultured hESCs. Scale bar = 200 µm. Arrows indicate the direction of the nanofibers. (B) Qualitative gene expression was investigated at different time points (Day 0, 5, 10 and 20) during spontaneous differentiation by RTPCR followed by gel electrophoresis. Genes investigated include: GAPDH (housekeeping gene), POU5F1 (pluripotent marker), TERT (pluripotent marker), SOX1 (ectoderm germ layer), ACTC1 (mesoderm germ layer) and AFP (endoderm germ layer).

Figure 6: Reduced PCL nanofibrous substrate fiber diameters enhance hESC clonogenicity. (A) FESEM characterization of PCL nanofibrous substrates (aligned and random) with large and small fiber diameters. Nanofiber diameters are indicated under each image. An arrow indicates the predominant direction of fiber orientation. Scale bar = 3 µm. (B) Average fiber diameters for large and small PCL fibers in aligned and random conformations. The y-axis indicates the mean fiber diameter (mm) while error bars indicate positive standard deviations of n=20; a p < 0.05, b p < 0.01, c p < 0.001. (C) Quantification of the number of hESC colonies recovered on PCL nanofibrous substrates with various fiber diameters, in both aligned and random conformations; in physiological normoxia (2 % O2) for 21 days. The y-axis indicates the average number of hESC colonies formed on various fiber diameter PCL nanofibrous substrates (x-axis), with positive standard deviations of n=20; a p < 0.05, b p < 0.01, c p < 0.001. (D) Characterization of hESC CFU morphology on: PCL smaller fiber diameter (aligned, 280 nm; random, 318 nm), PCL larger fiber diameter (aligned, 521 nm; random 660 nm), and MatrigelTM (positive control).


Table 1: Polymer and electrospinning operating parameters used to fabricate aligned and random nanofibrous scaffolds.
Parameter	12.5 % PCL	15 % PCL	2 % PLGA	7 % PLLA
Flow Rate [mL/min]	0.01	0.01	0.01	0.025
Needle 	22G blunt 	22G blunt 	22G blunt	18G blunt
Working Distance [cm]	Aligned: 20Random: 15	Aligned: 20Random: 15	Aligned: 20Random: 15	Aligned: 20Random: 15





Table 2.  Primer design and annealing temperature of the genes investigated.






ACTC-1	5’CATCCTGACC CTGAAGTATCCCATC3’	5’CCCTCATAGATGGGGACATTGT GAG3’	56 ºC
AFP	5’CAGAAAAATGGCAGCCACAGC3’	5’TGGCAGCATTTCTCCAACAG G3’	54 ºC
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